# Study of VX-985 in Subjects With Chronic Hepatitis C

> **NCT01144936** · PHASE1 · COMPLETED · sponsor: **Vertex Pharmaceuticals Incorporated** · enrollment: 21 (estimated)

## Conditions studied

- Chronic Hepatitis C

## Interventions

- **DRUG:** VX-985 or matching placebo
- **DRUG:** VX-985 or matching placebo
- **DRUG:** VX-985 or matching placebo

## Key facts

- **NCT ID:** NCT01144936
- **Lead sponsor:** Vertex Pharmaceuticals Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2010-10
- **Final completion:** 2010-10
- **Target enrollment:** 21 (ESTIMATED)
- **Last updated:** 2011-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01144936

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01144936, "Study of VX-985 in Subjects With Chronic Hepatitis C". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT01144936. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*